Sigma Lithium Corporation(NASDAQ:SGML)

Sigma Lithium Corporation engages in the exploration and development of lithium deposits in Brazil. It holds 100% interest in the Grota do Cirilo, Genipapo, Santa Clara, and São José properties comprising 27 mineral rights covering an area of approximately 191 square kilometers located in the Araçua...
Founded: 2011
Full Time Employees: 126
CEO: Ana Cabral-Gardner
Sector: Basic Materials
Industry: Other Industrial Metals & Mining
Share this website to your friends
• Market Cap:
• Exchange:
• Shs Outstanding:
• Employees:
• Beta:
• Return on Equity (ROE) ttm:
• Return on Assets (ROA) ttm:
• EPS ttm:
• Book value per Share:
• Cash per Share:
• Current ast per Share:
• P/E ttm:
• P/E forward:
• P/E ttm high:
• P/E ttm low:
• P/S ttm:
• P/B ttm:
• P/FCF ttm:
• PEG ratio:
• Cash Ratio ttm:
• Quick Ratio ttm:
• Current Ratio ttm:
• Gross Mgn ttm:
• EBITDA Mgn ttm:
• Operating Mgn ttm:
• Net Income Mgn ttm:
• Trailing Div yield:
• Forward Div yield:
• Payout Ratio ttm:
• Ex-Dividend date:
• Target Price High:
• Target Price Low:
• Target Price Mean:
• Number of Analysts:
• Debt Ratio ttm:
• Debt to Equity ttm:
• Total Net Debt:
At a glance:
Bull Thesis:
Bear Thesis:
Main Competitors:
Moat:
Income Statements:
Quarterly
Annual
| Unit: USD | 2025-08-15 | 2025-03-31 | 2024-11-15 | 2024-09-30 | 2024-06-30 | 2022-03-31 |
|---|---|---|---|---|---|---|
net sales revenue | 16,888 | |||||
cost of goods sold & distribution | -23,564 | -34,217 | -39,733 | |||
gross profit | -6,676 | 13,456 | -11,458 | -11,458,000 | 22,145,000 | |
yoy | -100.03% | |||||
qoq | -149.61% | -217.44% | -99.90% | -151.74% | ||
gross margin % | -Infinity% | 28.23% | -40.52% | -Infinity% | Infinity% | NaN% |
sales expense | -183 | -205 | -535 | |||
g&a expense | -4,336 | -4,759 | -7,163 | |||
stock-based compensation | -472 | -805 | -1,871 | -1,871,000 | -2,656,000 | 10,681,000 |
esg and other operating expenses | -8,491 | -896 | -416 | |||
ebit | -20,158 | 6,791 | -21,444 | |||
financial income and (expenses) | 1,299 | -5,447 | -11,277 | |||
income before taxes | -18,859 | 9,728 | -32,998 | |||
income taxes and social contribution | -5,000 | -1,247 | ||||
net income for the period | -18,859 | 4,728 | -34,246 | -34,246,000 | ||
weighted-average number of common shares outstanding | 111,280 | 111,271 | ||||
earnings per share | -0.17 | 0.04 | -0.31 | |||
revenue | 47,673 | 28,275 | ||||
yoy | ||||||
qoq | 68.60% | |||||
non-cash fx & other income (expenses) | 8,384 | -278 | ||||
sales revenues | 59,887 | 59,887,000 | ||||
provisional price adjustments | -31,612 | -31,612,000 | ||||
weighted avg diluted shares outstanding | 110,822 | |||||
total sales revenue | 28,275,000 | |||||
cost of goods sold | -39,733,000 | -40,712,000 | ||||
operating expenses | ||||||
sales expenses and commissions | -535,000 | -515,000 | ||||
general and administrative expenses | -7,163,000 | -6,297,000 | 1,359,000 | |||
other operating income (expenses) | -416,000 | -4,966,000 | ||||
operating income before financial results and income taxes | -21,443,000 | 7,711,000 | ||||
financial income (expenses) | -11,555,000 | -25,498,000 | ||||
income (loss) before income tax and social contribution | -32,998,000 | |||||
income tax and social contribution – current | -624,000 | -6,211,000 | ||||
income tax and social contribution – deferred | -624,000 | 9,177,000 | ||||
basic and diluted net income per common share | -310 | |||||
weighted average number of common shares outstanding - basic and diluted | 110,821,505,000 | |||||
sales revenue | 62,857,000 | |||||
loss before income tax and social contribution | -17,787,000 | |||||
net loss for the period | -14,821,000 | -10,204,000 | ||||
basic and diluted net loss per common share | -130 | -100 | ||||
weighted-average number of common shares outstanding - basic and diluted | 110,528,083,000 | 99,770,691,000 | ||||
accretion and interest on notes payable | 15,000 | |||||
interest expense on credit revolver and suppliers | ||||||
foreign exchange loss | -1,873,000 | |||||
depreciation | 22,000 | |||||
other comprehensive income | ||||||
amounts that may be reclassified subsequently to profit and loss | ||||||
cumulative translation adjustment | 1,345,000 | |||||
net loss and comprehensive loss for the period | -8,859,000 | |||||
loss per common share | ||||||
equity holders of the company |
Balance Sheets:
Quarterly
Annual
| Unit: USD | 2025-08-15 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-11-15 | 2024-09-30 | 2024-08-16 | 2024-06-30 | 2024-05-16 | 2023-11-14 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
assets | |||||||||||||||||
cash and cash equivalents | 15,113 | 15,113 | 31,111 | 66,053 | 88,645 | 88,645,000 | 103,090 | 103,090,000 | 146,393 | 38,142,000 | 45,617,000 | 92,852,000 | 35,486,829 | ||||
trade accounts receivable | 16,765 | 16,765 | 27,035 | 16,663 | 20,122 | 20,109,000 | 89,846 | 89,846,000 | 39,276 | ||||||||
inventories | 24,566 | 24,566 | 21,232 | 23,217 | 22,394 | 22,394,000 | 19,272,000 | 21,797 | 21,797,000 | 24,107,000 | 721,000 | ||||||
other current assets | 13,306 | 13,306 | 21,208 | 27,517 | 24,883 | 39,821 | 51,114 | ||||||||||
total current assets | 69,750 | 69,750 | 100,585 | 133,450 | 156,044 | 156,044,000 | 232,757 | 232,757,000 | 236,783 | 153,363 | 153,363,000 | 89,564,000 | 113,659,000 | 86,436,000 | 124,602,000 | 142,729,000 | 36,384,258 |
property, plant and equipment | 161,617 | 161,617 | 152,533 | 202,864 | 224,945 | 224,945,000 | 223,269 | 223,269,000 | 236,824 | 232,138 | 232,138,000 | 231,791,000 | 211,052,000 | 89,264,000 | 52,760,000 | 41,103,000 | 25,651,557 |
other non-current assets | 104,834 | 104,834 | 98,815 | 134,244 | 117,459 | 110,611 | 107,613 | ||||||||||
total assets | 266,451 | 266,451 | 351,934 | 470,559 | 498,447 | 498,447,000 | 566,637 | 566,637,000 | 581,220 | 455,011 | 455,011,000 | 381,479,000 | 363,720,000 | 197,564,000 | 193,319,000 | 195,781,000 | 66,542,285 |
liabilities & shareholder equity | |||||||||||||||||
financing and export prepayment | 53,655 | 53,655 | 55,786 | 88,606 | 94,573 | 148,858 | 127,149 | 13,872,000 | 14,050,000 | ||||||||
suppliers & accounts payable | 44,325 | 44,325 | 41,289 | 46,933 | |||||||||||||
other current liabilities | 17,359 | 17,359 | 20,248 | 20,928 | 33,082 | 21,888 | 32,047 | ||||||||||
total current liabilities | 115,339 | 115,339 | 117,323 | 156,468 | 185,251 | 185,251,000 | 222,507 | 222,507,000 | 222,114 | 99,776 | 99,776,000 | 76,992,000 | 53,108,000 | 9,445,000 | 9,542,000 | 2,107,000 | 2,673,676 |
other non-current liabilities | 15,639 | 15,639 | 14,736 | 20,144 | 15,029 | 14,858 | 8,344 | ||||||||||
total non-current liabilities | 128,939 | 128,939 | 127,617 | 181,261 | 165,303 | 165,304,000 | 166,401 | 166,401,000 | 153,832 | 136,605 | 136,605,000 | 129,947,000 | 133,418,000 | 2,315,000 | 4,749,000 | 4,439,000 | |
total shareholders' equity | 91,923 | 91,923 | 106,994 | 132,830 | 147,893 | 147,892,000 | 177,729 | 177,729,000 | 205,274 | 218,630 | 218,630,000 | 174,540,000 | 177,194,000 | 185,804,000 | 179,028,000 | 189,235,000 | 59,641,247 |
total liabilities & shareholders' equity | 336,201 | 336,201 | 351,934 | 470,559 | 566,637 | 581,220 | |||||||||||
liabilities& shareholder equity | |||||||||||||||||
suppliers& accounts payable | 57,596 | ||||||||||||||||
total liabilities& shareholders' equity | 498,447 | ||||||||||||||||
financial position | |||||||||||||||||
advance to suppliers | 11,323,000 | 7,317,000 | 9,441 | 9,441,000 | 6,489,000 | 3,899,000 | |||||||||||
accounts receivable from related parties | 12,000 | 12,000 | |||||||||||||||
prepaid expenses and other assets | 2,532,000 | 1,267,000 | 6,869 | 6,869,000 | 12,963,000 | 15,826,000 | 1,250,000 | 1,317,000 | 1,834,000 | ||||||||
recoverable vat and other taxes | 11,029,000 | 11,953,000 | |||||||||||||||
loans and accounts receivable from related parties | 16,760,000 | 12,746,000 | |||||||||||||||
deferred income tax and social contribution | 10,973,000 | 11,626,000 | 1,757 | 1,757,000 | |||||||||||||
cash held as collateral | 15,564,000 | 15,761,000 | |||||||||||||||
deferred exploration and evaluation expenditure | 72,062,000 | 70,402,000 | |||||||||||||||
total non-current assets | 342,403,000 | 333,880,000 | |||||||||||||||
suppliers | 47,645,000 | 44,164,000 | 37,425 | 37,425,000 | 19,929,000 | 19,553,000 | |||||||||||
loans and export prepayment | 94,573,000 | 148,858,000 | |||||||||||||||
lease liability | 1,658,000 | 1,889,000 | 2,089 | 2,089,000 | 1,802,000 | 1,385,000 | 48,000 | 39,000 | 31,000 | 27,572 | |||||||
prepayment from customers | 8,247,000 | ||||||||||||||||
taxes payable | 13,441,000 | 12,031,000 | 4,594,000 | 3,337,000 | 6,020,000 | ||||||||||||
accounts payable | 9,951,000 | 51,761 | 7,598,000 | 62,918 | 9,399,000 | 2,023,166 | |||||||||||
payroll and related charges | 7,819,000 | 5,866,000 | 2,902 | 2,902,000 | 1,499,000 | 838,000 | |||||||||||
legal contingencies | 87,000 | ||||||||||||||||
other liabilities | 1,830,000 | 2,101,000 | 162,000 | 134,000 | 122,000 | ||||||||||||
legal contingencies - long term | 2,269,000 | ||||||||||||||||
labor provision | 1,168,000 | ||||||||||||||||
asset retirement obligations | 3,630,000 | 3,551,000 | 7,216 | 7,216,000 | 7,272,000 | 6,919,000 | 2,105,000 | 529,000 | 188,000 | ||||||||
share capital | 423,499,000 | 417,192,000 | 373,043 | 373,043,000 | 309,701,000 | 297,779,000 | 231,810,000 | 231,356,000 | 229,709,000 | 92,646,319 | |||||||
stock-based compensation reserve | 32,542,000 | 35,506,000 | |||||||||||||||
accumulated other comprehensive income | -17,090,000 | -18,157,000 | 923,000 | 4,012,000 | |||||||||||||
accumulated losses | -291,059,000 | -256,812,000 | -220,016,000 | ||||||||||||||
total liabilities and shareholders' equity | 498,447,000 | 566,637,000 | 455,011 | 455,011,000 | 381,479,000 | 363,720,000 | 197,564,000 | 193,319,000 | 195,781,000 | 66,542,285 | |||||||
labor contingencies | 3,469,000 | ||||||||||||||||
asset | |||||||||||||||||
current assets | |||||||||||||||||
cash and cash equivalent | 38,142 | ||||||||||||||||
customers | 73,492 | 73,492,000 | |||||||||||||||
due from related party | 370 | 370,000 | 388,000 | 361,000 | |||||||||||||
tax to recovery | 3,252 | ||||||||||||||||
non-current assets | |||||||||||||||||
exploration and evaluation assets | 59,706 | 59,706,000 | 54,029,000 | 38,716,000 | 21,660,000 | 15,865,000 | 11,846,000 | 4,409,587 | |||||||||
liabilities and shareholders' equity | |||||||||||||||||
current liabilities | |||||||||||||||||
financing and export prepayment agreement | 27,642 | 27,642,000 | |||||||||||||||
customer advance | 2,127 | 31,752,000 | |||||||||||||||
taxes payable - short term | 4,594 | ||||||||||||||||
income tax and social contribution | 8,800 | 8,800,000 | |||||||||||||||
account payable | 9,399 | 2,877,000 | 3,501,000 | 3,182,000 | 3,470,000 | 1,312,000 | |||||||||||
royal agreement option | |||||||||||||||||
royalties | 1,112 | 1,112,000 | |||||||||||||||
accrued social projects | 2,173 | 2,173,000 | 1,819,000 | 2,518,000 | |||||||||||||
accrued liabilities and other liabilities | 1,513 | ||||||||||||||||
non-current liabilities | |||||||||||||||||
taxes payable - long term | 136 | ||||||||||||||||
accrued liabilities | 2,354 | 1,513,000 | 105,000 | 107,000 | |||||||||||||
related party loan | |||||||||||||||||
total liabilities | 236,381 | 236,381,000 | 206,939,000 | 186,526,000 | 11,760,000 | 14,291,000 | 6,546,000 | 6,901,038 | |||||||||
shareholders' equity | |||||||||||||||||
contributed surplus | 64,680 | 64,680,000 | 129,728,000 | 103,429,000 | 70,911,000 | 48,107,000 | 39,023,000 | 21,896,165 | |||||||||
accumulated other comprehensive loss | 923 | 344,000 | -2,955,000 | -2,896,000 | -2,174,000 | -3,370,543 | |||||||||||
accumulated deficit | -220,016 | -268,901,000 | -224,358,000 | -113,962,000 | -97,539,000 | -77,323,000 | -51,530,694 | ||||||||||
tax recoverable | 3,252,000 | ||||||||||||||||
advances from customers | 2,127,000 | ||||||||||||||||
royalty agreement option | 5,136,000 | ||||||||||||||||
cash | 85,186,000 | 123,285,000 | 140,895,000 | ||||||||||||||
payroll and other taxes | 855,000 | 1,007,000 | 642,000 | 354,083 | |||||||||||||
note payable | 268,855 | ||||||||||||||||
royalty agreement call option | 5,198,000 | 4,892,000 | |||||||||||||||
deferred revenue | 4,007,000 | 4,007,000 | 4,007,100 | ||||||||||||||
receivables and other assets | 897,429 | ||||||||||||||||
revolving credit facility | |||||||||||||||||
long-term liabilities |
Cashflow Statements:
Quarterly
Annual
| Unit: USD | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
net sales revenue | ||||||||||||
cost of goods sold & distribution | -34,217 | |||||||||||
gross profit | 13,456 | |||||||||||
sales expense | ||||||||||||
g&a expense | -4,759 | |||||||||||
stock-based compensation | -805 | 1,868,000 | 2,656,000 | 3,066,000 | -2,391,000 | 29,312,000 | 19,705,000 | 17,511,000 | 10,661,000 | 10,681,000 | ||
esg and other operating expenses | ||||||||||||
ebit | 6,791 | |||||||||||
financial income and (expenses) | ||||||||||||
income before taxes | ||||||||||||
income taxes and social contribution | ||||||||||||
net income for the period | -18,859 | 4,728 | ||||||||||
weighted-average number of common shares outstanding | ||||||||||||
earnings per share | ||||||||||||
consolidated statements of financial position | ||||||||||||
assets | ||||||||||||
cash and cash equivalents | ||||||||||||
trade accounts receivable | 69,957,000 | -56,767,000 | -9,889,000 | |||||||||
inventories | -2,859,000 | -2,195,000 | -885,000 | 3,285,000 | ||||||||
other current assets | ||||||||||||
total current assets | ||||||||||||
property, plant and equipment | ||||||||||||
other non-current assets | ||||||||||||
total assets | ||||||||||||
liabilities & shareholder equity | ||||||||||||
financing and export prepayment | 23,544,000 | 0 | 57,414,000 | |||||||||
suppliers & accounts payable | ||||||||||||
other current liabilities | ||||||||||||
total current liabilities | ||||||||||||
other non-current liabilities | ||||||||||||
total non-current liabilities | ||||||||||||
total shareholders' equity | ||||||||||||
total liabilities & shareholders' equity | ||||||||||||
consolidated statements of cash flows | ||||||||||||
operating activities | ||||||||||||
adjustments, including fx movements | -21,906 | 3,203 | ||||||||||
interest payment on loans and leases | 7,793 | -1,149 | 21,085,679 | -4,255,000 | -1,654,000 | -15,194,000 | ||||||
adjustments to income for the period | -14,113 | 2,054 | ||||||||||
change in working capital | 12,822 | -8,968 | ||||||||||
net cash from operating activities | -6,019 | -2,186 | 7,710,653 | 48,190,000 | -40,533,000 | -15,392,000 | -16,175,000 | -28,812,000 | -35,332,000 | -8,557,000 | -2,771,000 | -4,310,000 |
capital expenditures | 0 | 0 | 0 | -2,133,000 | -11,941,000 | -5,303,000 | -9,207,000 | -13,979,000 | -26,289,000 | -28,397,000 | -12,134,000 | -7,275,000 |
free cash flows | -6,019 | -2,186 | 7,710,653 | 46,057,000 | -52,474,000 | -20,695,000 | -25,382,000 | -42,791,000 | -61,621,000 | -36,954,000 | -14,905,000 | -11,585,000 |
investing activities | ||||||||||||
purchase of ppe | -3,025 | -3,454 | ||||||||||
addition to exploration and evaluation assets | -249 | -296 | -5,115,000 | -5,736,000 | -1,592,000 | -5,065,000 | -4,040,000 | -2,766,000 | ||||
other | 1 | -1,043 | -3,049,244 | 258,000 | 1,183,000 | 1,603,000 | ||||||
net cash from investing activities | -3,273 | -4,793 | 27,472,440 | -6,521,000 | -13,378,000 | -7,606,000 | -14,322,000 | -19,715,000 | -27,881,000 | -33,462,000 | -16,174,000 | -10,041,000 |
financing activities | ||||||||||||
proceeds of loans | -6,449 | -10,193 | ||||||||||
net cash from financing activities | -7,096 | -10,772 | -68,759,884 | -57,025,000 | 19,841,000 | 106,016,000 | 23,544,000 | 0 | 57,414,000 | 21,000 | 58,000 | 2,006,000 |
effect of fx | 400 | 2,944 | ||||||||||
net increase in cash | -15,998 | -14,807 | -38,099,000 | -17,610,000 | -13,410,000 | |||||||
cash & equivalents, beg of period | 0 | 45,918 | ||||||||||
cash & equivalents, end of period | -15,998 | 31,111 | ||||||||||
| 7 | ||||||||||||
cash-cost to cost of sales reconciliation | 1 | |||||||||||
operating cash cost at plant gate | 349 | |||||||||||
freight to port & warehouse | 51 | |||||||||||
cif freight & distribution cost | 36 | |||||||||||
royalties | 22 | |||||||||||
operating cash cost cif china | 458 | |||||||||||
freight accounting adjustments | 23 | |||||||||||
d&a expenses | 46 | |||||||||||
inventory and other accounting adjustments | 28 | |||||||||||
cost of sales | 556 | |||||||||||
ebitda | 10,010 | |||||||||||
revenues | 47,673 | |||||||||||
sales expenses | -205 | |||||||||||
esg & other operating expenses | -896 | |||||||||||
depreciation & amortization | 3,219 | |||||||||||
adjusted cash ebitda | 11,426 | |||||||||||
adjusted ebitda | 24 | |||||||||||
net loss for the period | -34,247,000 | -14,711,000 | -9,344,000 | -29,847,000 | -16,423,000 | -20,216,000 | -10,204,000 | |||||
adjustments for: | ||||||||||||
interest on loans and leases | 7,933,000 | 7,453,000 | 6,338,000 | |||||||||
depreciation and depletion | 3,912,000 | 4,148,000 | 4,622,000 | |||||||||
reversal of present value of assets retirement obligation | 51,000 | 55,000 | 57,000 | |||||||||
provision for labor and legal contingencies | ||||||||||||
amortization of transaction costs | 249,000 | 262,000 | 267,000 | |||||||||
foreign exchange gain | -4,534,000 | 25,919,000 | 5,460,000 | |||||||||
income tax and social contribution - current and deferred | 1,247,000 | -2,966,000 | -585,000 | |||||||||
interest on loans with related parties | -414,000 | -227,000 | -567,000 | |||||||||
social programs provision | -945,000 | 530,000 | 110,000 | |||||||||
(increase) decrease in operating assets | ||||||||||||
prepaid expenses and other assets | -1,231,000 | 1,409,000 | 1,423,000 | 139,000 | -3,931,000 | -5,007,000 | -36,000 | 548,000 | -1,035,000 | |||
advance to suppliers | -3,947,000 | 167,000 | -1,438,000 | |||||||||
related parties | ||||||||||||
recoverable vat and other taxes | -3,936,000 | -3,708,000 | -2,652,000 | |||||||||
other assets | 55,000 | |||||||||||
increase (decrease) in operating liabilities | ||||||||||||
suppliers | 2,387,000 | -13,431,000 | 3,748,000 | 29,942,000 | ||||||||
prepayment from customer | 8,117,000 | |||||||||||
taxes payables | 3,754,000 | 7,090,000 | 1,262,000 | |||||||||
payroll and related charges | 1,892,000 | 1,361,000 | 2,525,000 | |||||||||
accounts payable | 2,885,000 | -318,000 | -3,269,000 | |||||||||
founder's royalty option | ||||||||||||
other liabilities | 182,000 | 393,000 | -27,000 | |||||||||
purchase of property, plant and equipment | -2,133,000 | -11,941,000 | -5,303,000 | -9,207,000 | -13,979,000 | -26,289,000 | -28,397,000 | -12,134,000 | -7,275,000 | |||
addition to deferred exploration and evaluation expenditure | -966,000 | -1,014,000 | -2,248,000 | |||||||||
loans to related parties for land acquisition and geology expenditures | -3,422,000 | -423,000 | -55,000 | |||||||||
proceeds from loans | 38,801,000 | 65,250,000 | 119,380,000 | |||||||||
repayment of loan | -95,348,000 | -45,212,000 | -12,518,000 | |||||||||
transactions costs | 0 | |||||||||||
payment of lease liabilities | -478,000 | 40,000 | -846,000 | |||||||||
effect of exchange rate changes on cash held in foreign currency | 911,000 | -9,233,000 | -1,028,000 | -522,000 | 1,292,000 | 2,297,000 | 3,899,000 | 1,277,000 | -1,065,000 | |||
increase (decrease) in cash and cash equivalents in the period | 81,990,000 | |||||||||||
cash and cash equivalents, beginning of period | 0 | 0 | 64,403,000 | |||||||||
cash and cash equivalents, end of period | -14,445,000 | -43,303,000 | 146,393,000 | -7,475,000 | -47,235,000 | 92,852,000 | ||||||
provision for labor contingencies | 2,775,000 | 116,000 | ||||||||||
decrease in operating assets | ||||||||||||
increase in operating liabilities | ||||||||||||
increase in cash and cash equivalents in the period | ||||||||||||
prepayment from customer for by-products | -2,139,000 | |||||||||||
interest and additions on notes payable | ||||||||||||
accrual social projects | ||||||||||||
accrual liabilities | ||||||||||||
cost transactions | 270,000 | 265,000 | 255,000 | |||||||||
interest due loans and leases | 1,907,000 | 759,000 | 214,000 | |||||||||
accretion of asset retirement obligation | ||||||||||||
realized foreign exchange loss on notes payable | 0 | 0 | 41,000 | |||||||||
deferred revenue termination agreement | ||||||||||||
foreign exchange loss on other assets and liabilities | -6,093,000 | 1,046,000 | -1,873,000 | |||||||||
royalty agreement call option | 0 | |||||||||||
adjusted income for the period | ||||||||||||
changes in non-cash working capital items: | ||||||||||||
customers | ||||||||||||
advance from customers | ||||||||||||
amounts payable and other liabilities | 5,000 | -111,000 | -2,159,000 | |||||||||
payroll and other taxes | 1,422,000 | -2,099,000 | 3,041,000 | -151,000 | 382,000 | 202,000 | ||||||
interest payment of leases and financing | -1,315,000 | -178,000 | -190,000 | |||||||||
proceeds from warrants exercised | 0 | 0 | 2,345,000 | |||||||||
proceeds from stock options exercised | 22,000 | |||||||||||
repayment of note payable | 0 | 1,000 | -326,000 | |||||||||
net (decrease) in cash and cash equivalents | ||||||||||||
non-cash transactions | ||||||||||||
addition in pp&e – right of use – ifrs 16 - | ||||||||||||
capitalized interest | 38,000 | 153,000 | 3,608,000 | |||||||||
pp&e suppliers outstanding balances | -9,816,000 | 14,629,950 | 14,050 | |||||||||
non-cash effects | -8,270,000 | 20,068,182 | 18,818 | |||||||||
loss for the period | ||||||||||||
depreciation | 41,000 | 34,000 | 15,000 | 27,000 | 22,000 | |||||||
interest and accretion on notes payable | 18,000 | 0 | 15,000 | |||||||||
accrual for social projects | -774,000 | 2,454,000 | ||||||||||
accrual for contingencies | 7,000 | 163,000 | ||||||||||
accretion due to asset retirement obligation | ||||||||||||
foreign exchange gain on other assets and liabilities | ||||||||||||
adjusted loss for the period | ||||||||||||
customer advance | ||||||||||||
accounts payable and other liabilities | ||||||||||||
net decrease in cash and cash equivalents | ||||||||||||
cash and cash equivalents, at beginning of period | 0 | 96,354,000 | ||||||||||
addition in pp&e – right of use – ifrs 16 | 522,000 | 1,160,000 | ||||||||||
adjusted net loss for the period | -13,115,000 | |||||||||||
suppliers, accounts payable and other liabilities | -20,061,000 | |||||||||||
net increase in cash and cash equivalents | -3,502,000 | |||||||||||
interest expense on credit revolver and suppliers | ||||||||||||
repayment of revolving credit facility | ||||||||||||
lease payments | -1,000 | -10,000 | -13,000 | |||||||||
issuance of common shares | ||||||||||||
cash, beginning of period | 0 | 0 | 154,305,000 | |||||||||
cash, end of period | -38,099,000 | -17,610,000 | 140,895,000 | |||||||||
unrealized foreign exchange loss on notes payable | ||||||||||||
accretion and interest on notes payable | ||||||||||||
fair value adjustment on restructuring of note payable | ||||||||||||
unrealized foreign exchange gain on notes payable | ||||||||||||
unrealized foreign exchange gain | ||||||||||||
provision | ||||||||||||
receivables and other assets | ||||||||||||
other taxes | ||||||||||||
issue of common shares |
